Volinanserin
Volinanserin ( ; developmental code MDL-100,907) is a highly selective 5-HT 2A receptor antagonist that is frequently used in scientific research to investigate the function of the 5-HT 2A receptor.
≈ 2 min read
Volinanserin. encyclopegia.org, snapshot enwiki-001375670031. /a/volinanserin
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Volinanserin ( ; developmental code MDL-100,907) is a highly selective 5-HT 2A receptor antagonist that is frequently used in scientific research to investigate the function of the 5-HT 2A receptor. It was also tested in clinical trials as a potential antipsychotic, antidepressant, and treatment for insomnia but was never marketed.
The drug reached phase 3 trials for schizophrenia and insomnia prior to the discontinuation of its development in the late 2000s. It is taken orally.
Pharmacokinetics
The time to peak levels of volinanserin is 1 to 2.5 hours. The elimination half-life of volinanserin is 6.6 hours, with a range of 4.5 to 9.8 hours. However, cortical serotonin 5-HT 2A receptor occupancy with volinanserin measured by positron emission tomography (PET) imaging lasts much longer than its circulating elimination half-life would imply.
Synthesis
The synthesis of volinanserin has been reported. Beginning with protection of ethyl isonipecotate (1) with Boc anhydride gives ethyl N-Boc-4-piperidinecarboxylate (2). Ester-amide interchange with N-methoxymethylamine HCl in the presence of carbonyldiimidazole (CDI) coupling agent gives 1-Boc-4-[methoxy(methyl)carbamoyl]piperidine (3).
Weinreb ketone synthesis occurs upon benzoylation with 1,2-dimethoxybenzene (4) to give 1-Boc-4-(2,3-dimethoxybenzoyl)piperidine (5). Acid removal of the urethane protecting group gives (2,3-dimethoxyphenyl)-piperidin-4-ylmethanone (6). The reduction of the ketone with sodium borohydride leads to (2,3-dimethoxyphenyl)-piperidin-4-ylmethanol (7).
Resolution of the alcohol gives (8). S N 2 alkylation of the secondary nitrogen with 4-fluorophenethyl bromide (9) completes the synthesis of volinanserin (10).
See also
Serotonin 5-HT 2A receptor antagonist List of investigational antipsychotics List of investigational insomnia drugs Eplivanserin/volinanserin Glemanserin Pruvanserin Roluperidone Lenperone Lidanserin Ketanserin Ritanserin Eplivanserin Pimavanserin 4F-4PP
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375670031 under CC BY-SA 4.0; modifications have been made.